Sorrento Therapeutics' Reverse Merger Round

Sorrento Therapeutics raised a round of funding on July 15, 2009. Investors include QuickByte.

Sorrento Therapeutics (NASDAQ: SRNE) is a publicly-traded, development-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel and proprietary biotherapeu…

Articles about Sorrento Therapeutics' Reverse Merger Round: